These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28746017)

  • 1. Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?
    El-Deiry WS; Taylor B; Neal JW
    Am Soc Clin Oncol Educ Book; 2017; 37():e8-e15. PubMed ID: 28746017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
    Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
    Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Cause and Consequence of Tumor Heterogeneity.
    Khatib S; Pomyen Y; Dang H; Wang XW
    Trends Cancer; 2020 Apr; 6(4):267-271. PubMed ID: 32209440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population genetics perspective on the determinants of intra-tumor heterogeneity.
    Hu Z; Sun R; Curtis C
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Multidimensional Evolutionary Forces to Combat Cancer.
    McCoach CE; Bivona TG
    Cancer Discov; 2019 May; 9(5):587-604. PubMed ID: 30992280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
    Chan FC; Lim E; Kridel R; Steidl C
    J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
    Biswas A; De S
    Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing intra-tumoral heterogeneity and therapy resistance.
    Rybinski B; Yun K
    Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenges of tumor genetic diversity.
    Mroz EA; Rocco JW
    Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing mutational and adaptive landscapes and the genesis of cancer.
    Liggett LA; DeGregori J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance.
    Zhang A; Miao K; Sun H; Deng CX
    Int J Biol Sci; 2022; 18(7):3019-3033. PubMed ID: 35541919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology in real time.
    Ryška A
    Cancer Metastasis Rev; 2016 Mar; 35(1):129-40. PubMed ID: 26931654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cancer metabolism on therapy resistance - Clinical implications.
    Gonçalves AC; Richiardone E; Jorge J; Polónia B; Xavier CPR; Salaroglio IC; Riganti C; Vasconcelos MH; Corbet C; Sarmento-Ribeiro AB
    Drug Resist Updat; 2021 Dec; 59():100797. PubMed ID: 34955385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapy in cancer.
    Tsimberidou AM
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor heterogeneity-driven individualized therapy.
    Baltagiannis EG; Ziogas DE; Cho WC; Mitsis M; Roukos DH
    Future Oncol; 2021 Jan; 17(3):235-240. PubMed ID: 33305621
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor microenvironment and cancer therapy resistance.
    Sun Y
    Cancer Lett; 2016 Sep; 380(1):205-15. PubMed ID: 26272180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
    Apostoli AJ; Ailles L
    Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary scalpels for dissecting tumor ecosystems.
    Rosenbloom DIS; Camara PG; Chu T; Rabadan R
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.